Ultrasonographic Axillary Localization
Primary Purpose
Breast Neoplasm
Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Ultrasonographical tattooing of suspicious axillary lymph nodes.
Sentinel lymph node biopsy
Histopathological examination of the axillary nodes
Further axillary management
Sponsored by
About this trial
This is an interventional diagnostic trial for Breast Neoplasm focused on measuring sentinel lymph node biopsy, Axillary ultrasonography
Eligibility Criteria
Inclusion Criteria:
- Biopsy-proven invasive breast adenocarcinoma.
- Clinically non palpable axillary lymph nodes.
- T0-3, N0, M0
- Scheduled for definitive surgery.
Exclusion Criteria:
- Patient unwilling to participate.
- Contraindication to methylene blue technique: hypersensitivity, pregnancy.
- T4 primary tumor.
- Previous axillary surgery.
Sites / Locations
- Mansoura University Oncology CenterRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Pre-sentinel node biopsy ultrasonographical tattooing
Arm Description
Preoperative ultrasonographical tattooing of the suspicious lymph nodes. Sentinel Lymph Node Biopsy (SLNB),
Outcomes
Primary Outcome Measures
Sensitivity of ultrasonographical tattooing
The ratio of the tattooed lymph nodes (that are positive by histopathological examination) to the sentinel lymph nodes (that are positive by histopathological examination).
Identification benefit of the ultrasonographical tattooing.
The ratio of the cases with successfully tattooed nodes and non identified sentinel node to the total number of analyzed cases.
Secondary Outcome Measures
Full Information
NCT ID
NCT04644848
First Posted
November 24, 2020
Last Updated
February 24, 2021
Sponsor
Mansoura University
1. Study Identification
Unique Protocol Identification Number
NCT04644848
Brief Title
Ultrasonographic Axillary Localization
Official Title
Diagnostic Accuracy of Preoperative Ultrasonographic Tattooing of Suspicious Axillary Lymph Nodes in Breast Cancer Patients With Clinically Negative Axilla. A Prospective Cohort Study.
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
December 15, 2020 (Actual)
Primary Completion Date
January 2022 (Anticipated)
Study Completion Date
April 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Breast cancer is the most common cancer of women. Surgery for early breast cancer includes axillary lymph nodes staging. Axillary surgery may lead to intractable complications like permanent arm swelling. Axillary sentinel lymph node biopsy (SLNB) has been introduced to minimize the incidence of these complications. Several methods are routinely used for identification of the sentinel node during operation. Some of these methods necessitate facilities that are not universally available; specially in countries with limited resources. In its simplest form, SLNB using the methylene blue dye technique has an identification rate of 88-94%. If the sentinel node can not be identified, full axillary dissection may be required and the risk of arm swelling is increased. The objective of this study is to maximize the identification rate of the sentinel node thus avoiding the need for extensive axillary surgery. The investigators assumed that preoperative tattooing of the suspicious lymph node during ultrasonographical imaging may help the surgeon in localizing the sentinel lymph node. In this study, the sonographer will perform preoperative tattooing of the suspicious node. The surgeon will perform SLNB by the methylene blue dye. The sensitivity of ultrasonographical tattooing relative to SLNB will be calculated. The study will determine if the tattooing technique may localize additional nodes that are missed by the methylene blue.
Detailed Description
Introduction Axillary nodal staging is an integral part of breast cancer management. Sentinel lymph node biopsy (SLNB) has become a standard of care in patients with clinically negative axillae. Various methods have been investigated to decrease the false negative rate of SLNB. Ultrasonography is an established tool for preoperative axillary staging. The diagnostic accuracy of B-mode ultrasonographic criteria and of US-guided FNAC (Fine Needle Aspiration Cytology) has been described in the literature and its role in preoperative axillary staging has been emphasized.
Ultrasonographic aspiration of suspicious axillary nodes are widely used to identify axillary metastases and obviate the need for SLNB. Previous studies retrospectively examined the concordance of ultrasonographic identification of suspicious lymph nodes with subsequent SLNB results. However, ultrasonographic axillary staging have not been prospectively compared to SLNB. In addition, concomitant ultrasonographic and SLNB are thought to increase the overall accuracy of axillary staging.
In this study, the investigators will perform preoperative ultrasonographic axillary evaluation and tattooing of suspicious lymph nodes followed by SLNB with methylene blue technique. Head-to-head and node-to-node comparison of ultrasonographic and surgical staging will be conducted.
Specific aims
Determination of the diagnostic accuracy of preoperative ultrasonic guided tattooing of suspicious axillary lymph nodes.
Determination of node-to-node concordance of ultrasonographic tattooing relative to blue dye SLNB.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasm
Keywords
sentinel lymph node biopsy, Axillary ultrasonography
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
75 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Pre-sentinel node biopsy ultrasonographical tattooing
Arm Type
Experimental
Arm Description
Preoperative ultrasonographical tattooing of the suspicious lymph nodes. Sentinel Lymph Node Biopsy (SLNB),
Intervention Type
Diagnostic Test
Intervention Name(s)
Ultrasonographical tattooing of suspicious axillary lymph nodes.
Intervention Description
Patients with clinically negative axillae scheduled for sentinel lymph node biopsy (SLNB) will have axillary ultrasonographical imaging of the ipsilateral axilla with a high-frequency linear probe. Suspicious lymph nodes are identified according to any of the following criteria:
Round shape.
Cortical thickness > 3 mm
Eccentric cortical thickness.
Loss of hilum.
For each patient, node dimensions and the presence of each of the above-mentioned criteria are recorded. Tattooing of all suspicious nodes is done using I ml of sterile liquid charcoal.
Intervention Type
Procedure
Intervention Name(s)
Sentinel lymph node biopsy
Intervention Description
Sentinel node biopsy is performed with peri-areolar subdermal injection of 3 ml methylene blue 5%. The lymphatics are tracked to the first blue lymph node. All blue, enlarged and /or tattooed nodes are separately biopsied and labelled as SLN and/or tattooed node.
Intervention Type
Diagnostic Test
Intervention Name(s)
Histopathological examination of the axillary nodes
Intervention Description
All tattooed nodes are excised and sent to frozen section examination; labelled tattoo node.
All enlarged or blue stained nodes are excised and sent to frozen section examination; labelled sentinel node.
All nodes are bisected and a single 5 um section examined. All frozen section examinations are followed by routine paraffin section examination.
Intervention Type
Procedure
Intervention Name(s)
Further axillary management
Intervention Description
Further axillary management is performed as per institutional guidelines. If SLNB is negative, no further surgery is required. Axillary lymph node dissection is performed if sentinel lymph node is positive or not identified. Management of positive SLNB as per the American College Of Surgeons' Oncology Group (ACOSOG) Z0011 protocol is not currently adopted on routine basis at the investigators' institution. In this study, patients with tattooed nodes with positive histopathological findings are offered full axillary dissection even if their sentinel nodes are negative.
Primary Outcome Measure Information:
Title
Sensitivity of ultrasonographical tattooing
Description
The ratio of the tattooed lymph nodes (that are positive by histopathological examination) to the sentinel lymph nodes (that are positive by histopathological examination).
Time Frame
at the date of surgery.
Title
Identification benefit of the ultrasonographical tattooing.
Description
The ratio of the cases with successfully tattooed nodes and non identified sentinel node to the total number of analyzed cases.
Time Frame
at the date of surgery.
Other Pre-specified Outcome Measures:
Title
Negative predictive value of ultrasonographical tattooing.
Description
The ratio of tattooed nodes (that are negative by histopathological examination) to the sentinel lymph nodes (that are negative by histopathological examination).
Time Frame
at the date of surgery.
Title
Concordance of ultrasonographical tattooing with sentinel lymph nodes.
Description
The ratio of cases that have similar histopathological examination results (of both tattooed and sentinel nodes) to the total number of analyzed cases.
Time Frame
at the date of surgery.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Biopsy-proven invasive breast adenocarcinoma.
Clinically non palpable axillary lymph nodes.
T0-3, N0, M0
Scheduled for definitive surgery.
Exclusion Criteria:
Patient unwilling to participate.
Contraindication to methylene blue technique: hypersensitivity, pregnancy.
T4 primary tumor.
Previous axillary surgery.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Osama Hussein, MD, PhD
Phone
+201099815110
Email
osamahussein@mans.edu.eg
Facility Information:
Facility Name
Mansoura University Oncology Center
City
Mansourah
State/Province
DK
ZIP/Postal Code
35516
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Osama Hussein, MD,PhD,FEBS
Phone
+2010 9981 5110
Email
osamahussein@mans.edu.eg
First Name & Middle Initial & Last Name & Degree
Eman Elnaghy
First Name & Middle Initial & Last Name & Degree
Mai Ali
First Name & Middle Initial & Last Name & Degree
Khadija Ali
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
28830644
Citation
Kim WH, Kim HJ, Jung JH, Park HY, Lee J, Kim WW, Park JY, Cheon H, Lee SM, Cho SH, Shin KM, Kim GC. Ultrasound-Guided Fine-Needle Aspiration of Non-palpable and Suspicious Axillary Lymph Nodes with Subsequent Removal after Tattooing: False-Negative Results and Concordance with Sentinel Lymph Nodes. Ultrasound Med Biol. 2017 Nov;43(11):2576-2581. doi: 10.1016/j.ultrasmedbio.2017.07.011. Epub 2017 Aug 19.
Results Reference
background
PubMed Identifier
30235340
Citation
Li J, Chen X, Qi M, Li Y. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis. PLoS One. 2018 Sep 20;13(9):e0204364. doi: 10.1371/journal.pone.0204364. eCollection 2018.
Results Reference
background
Learn more about this trial
Ultrasonographic Axillary Localization
We'll reach out to this number within 24 hrs